NEW YORK, March 13, 2020 (GLOBE NEWSWIRE) -- PRESS RELEASE -- In the midst of heightened uncertainty surrounding the risk of electronic nicotine delivery systems, the National Association of Cannabis Businesses (NACB) has announced the adoption of national standards for production, process safety controls and storage of cannabis-infused products. View the national standards here.

“Cannabis infusions continue to expand in scope and volume with little standardized control,” said Tom Nolasco, Director of Legal and Strategic Initiatives at the NACB. “This technical process requires guidance for the safety of consumers and reputation of the industry.”

“NACB Standards are designed to protect consumers and demonstrate to regulators and the public that our members operate at the highest levels of ethics and responsibility, especially when it comes to the safety and quality of their products,” said Adrienne Uthe, NACB’s Vice President, Sales and Marketing. “We’ve collaborated with cannabis industry experts, including our members Rebel Coast and Therapy Tonics, to define these best practices for cannabis-infused products. We’re committed to shaping cannabis into a safe, responsible and ethical industry.”

Nolasco leads the NACB’s National Standards initiatives. He is a 20-year litigator who entered the cannabis industry six years ago through partnership dispute cases. Previously, he served as co-chair of the Dickinson Wright National Cannabis Group. Nolasco has worked with municipal, state and federal legislators, including Representative Ed Perlmutter’s team on the SAFE Act. He is recognized nationally as an expert on medical and recreational cannabis laws on insurance.

Additional NACB Standards adopted and in progress include:

• Packaging & Labeling
• Advertising
• Lab Testing & Product Integrity
• Security
• Hemp (in progress)

EDMONTON, March 16, 2020 /CNW/ - PRESS RELEASE - Aurora Cannabis Inc., a Canadian cannabis company, has announced that Terry Booth has filed a report on the System for Electronic Disclosure by Insiders (SEDI) regarding his sale of approximately 12,161,900 shares into the open market. This transaction is in connection with the previously announced transition of Booth's role within the company.

Executive Chairman and Interim CEO Michael Singer stated, "The Board and management remain focused on the plan we laid out in February and we are progressing as planned toward appropriate capital allocation, balance sheet strength and profitability. We look forward to updating the markets on our next quarterly earnings call."

TORONTO, March 16, 2020 (GLOBE NEWSWIRE) -- PRESS RELEASE -- Aleafia Health Inc.’s wholly owned subsidiary, Aleafia Farms Inc., has secured a Health Canada Cultivation Licence for the company’s Niagara Production Facility, located in Grimsby, Ont.

“This is an important and long-awaited breakthrough for Aleafia Health. We can now fully leverage our supply chain across three completed, licensed production facilities,” said Aleafia Health CEO Geoffrey Benic. “The Niagara Facility provides both near term, stable inventory for our health and wellness sales channels, and the inputs needed for the 2020 outdoor cultivation season.”

The facility features a highly advanced, automated, moving container bench system, which allows for a perpetual, year-round harvest. Capital investments made in automated cultivation and quality assurance systems will assist in reducing both costs and execution risk. It will be used as a staging ground for the company’s planned 2020 outdoor cultivation at its Port Perry Facility. Starter plants will be grown on-site and transported to Port Perry at the beginning of the outdoor cultivation season, significantly reducing planting-to-harvest lead times.

The Niagara facility’s perpetual harvest offsets seasonal fluctuations in inventory inherent in outdoor cultivation and will ensure, consistent, standardized input material for medical and adult-use sales channels. The Licence, granted on March 13, 2020 after markets closed, expires on March 13, 2023 and authorizes cannabis cultivation, propagation, harvesting and sales in Building 1.

Building 1 includes 50,000 sq. ft. of greenhouse area and 20,000 sq. ft. for post-cultivation operations, including drying, storage and shipping and will also be used to support outdoor cultivation. The company expects to submit a Licence amendment application to Health Canada in the next 30 days to authorize production in the remaining 90,000 sq. ft. of greenhouse area.